Sign up to save your podcasts
Or
Share How research marketing can impact your organization, Part 2
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How research marketing can impact your organization, Part 2
Despite proven benefits, enrollment in clinical trials is sparse across the country. This episode of our award-winning podcast continues our discussion on the state of research today and how participation can positively impact patients and organizations alike. Two experts in research lay out all the facts.
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Senior Principal, Performance Improvement Consulting
Vizient
Guests:
Dylan Steen, MD, MS
Chief Executive Officer and Co-founder
High Enroll
Cardiologist, UC Health
Adjunct Associate Professor, UC College of Medicine
Daniel Flora, MD, PharmD
Medical Director, Oncology Research
Hematologist/Oncologist
St. Elizabeth Healthcare
Show Notes:
[01:31] Lack of inclusivity in trials – need for “real-world” participants
[04:05] Research organizations give standard of care that is lacking elsewhere
[04:50] Background for High Enroll and the program’s value: opportunities offered
[07:40] Latest generation of technology and information availability
[08:20] Improvement over other research sites (such as clinicaltrials.gov)
Links | Resources:
To contact Modern Practice: [email protected]
Dr. Steen’s email: [email protected]
Dr. Flora’s email: [email protected]
High Enroll website: https://www.highenroll.org
(513) 993-0330
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Android
Spotify
RSS Feed
View all episodes
By Dr. Tom Villanueva and Vizient Medical Leadership Team
4.8
2020 ratings
Despite proven benefits, enrollment in clinical trials is sparse across the country. This episode of our award-winning podcast continues our discussion on the state of research today and how participation can positively impact patients and organizations alike. Two experts in research lay out all the facts.
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Senior Principal, Performance Improvement Consulting
Vizient
Guests:
Dylan Steen, MD, MS
Chief Executive Officer and Co-founder
High Enroll
Cardiologist, UC Health
Adjunct Associate Professor, UC College of Medicine
Daniel Flora, MD, PharmD
Medical Director, Oncology Research
Hematologist/Oncologist
St. Elizabeth Healthcare
Show Notes:
[01:31] Lack of inclusivity in trials – need for “real-world” participants
[04:05] Research organizations give standard of care that is lacking elsewhere
[04:50] Background for High Enroll and the program’s value: opportunities offered
[07:40] Latest generation of technology and information availability
[08:20] Improvement over other research sites (such as clinicaltrials.gov)
Links | Resources:
To contact Modern Practice: [email protected]
Dr. Steen’s email: [email protected]
Dr. Flora’s email: [email protected]
High Enroll website: https://www.highenroll.org
(513) 993-0330
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Android
Spotify
RSS Feed